Live Breaking News & Updates on Thomas Rudel|Page 4

Stay updated with breaking news from Thomas rudel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic ...


Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Aeterna Zentaris Announces Evaluation and Potential Development of an Oral Prophylactic .
Aeterna Zentaris IncFebruary 2, 2021 GMT
- Company secures next step to continue to build-out pipeline of assets
- University researchers developed a proprietary and orally active bacterial vaccine platform technology currently undergoing pre-clinical studies for the prevention of coronavirus diseases, including COVID-19
- Aeterna Zentaris to evaluate the University’s coronavirus vaccine platform technology including COVID-19 under an exclusive option agreement
CHARLESTON, S.C., Feb. 02, 2021 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS), through its wholly-owned subsidiary Aeterna Zentaris GmbH, (“Aeterna” or the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced ....

United States , United Kingdom , Jenene Thomas , Thomas Rudel , Aeterna Zentaris Gmb , Klaus Paulini , Aeterna Zentaris , Company On Twitter , Megapharm Ltd , Aeterna Zentaris Inc , Wuerzburg The University , European Union , European Commission , World Health Organization , Exchange Commission , University Potential , Palestinian Authority , Consilient Health Ltd , Novo Nordisk , Paul Ehrlich Institute , Aeterna Zentaris Gmbh , Julius Maximilians University Wuerzburg , Chief Executive Officer , Consilient Health , Litigation Reform Act , Annual Report ,